Embedded Files
We greatly appreciate the value and roles of sound scientific literature, public dissemination of research results, and systematic knowledge building. Some of our contributions to such efforts are reflected in the following online records:
BIBLIOGRAPHY
Summarized Overviews
of Academic and Scholarly Contributions
by Our Intramural and Associate Principal Investigators
Marek Dudas, MD, PhD, Associate Professor
[Google Scholar]* [Elsevier Scopus] [Microsoft] [ResearchGate]
Daniel Hlinka, MVD, PhD
Robert Dankovcik, MD, PhD, MPH, Associate Professor
* Incomplete, but the most informative online bibliographic resource.
EXAMPLES OF OUR WORK
Major Focus:
Embryology / Birth Defects / Bio-Medical Imaging
(Selected from publicly disclosed items only)
● Tripolar mitosis in human cells and embryos: Occurrence, pathophysiology, and medical implications. Acta Histochemica 2015, 117 (1): 111-125. [PubMed] [ScienceDirect]
● Typology of numeric mitotic deviations in human early embryos. Oral Presentation - Original Research, Fertility 2015, Birmingham, UK. [Fertility 2015]
● Essentials of nano-scale x-ray imaging of mitotic errors. Abstract. ICXOM22, the 22nd International Congress on X-Ray Optics and Microanalysis, at DESY Hamburg, Germany 2013. [ResearchGate]
FIRST CLINICAL EMBRYO FILMING
● Time-lapse cleavage rating predicts human embryo viability. Physiol Res 2012, 61 (5): 513-25. [PubMed]
DESY / HASYLAB Scholarship Award
● Strategies to improve reproducibility of native biological specimens for atomic resolution imaging with x-ray laser pulses. Poster. X. Research Course on X-Ray Science, DESY, Hamburg 2011. [Download]
FIRST CLINICAL EMBRYO FILMING
● Permanent embryo monitoring and exact timing of early cleavages allow reliable prediction of human embryo viability. Poster P-176. Abstracts of the 26th Annual Meeting of the European Society of Human Reproduction and Embryology, Rome, Italy, 27 -30 June 2010. Human Reproduction 2010, 25 (Suppl 1): 1-339, i170-i210, P-176. [Hum Reprod] [Global IVF]
ScienceDirect TOP25 Hottest Articles INVITED REVIEW
(Medicine 2006-2011, Genetics 2006-2011)
● Palatal fusion - Where do the midline cells go? A review on cleft palate, a major human birth defect. Acta Histochemica 2007, 109: 1-14. [ScienceDirect TOP25] [PubMed]
Young Investigator Award
● Transforming growth factor-beta3 affects plasminogen activator inhibitor-1 expression in fetal mice and modulates fibroblast-mediated collagen gel contraction. Wound Repair Regen 2006, 14 (5):516-25. [Wiley] [PubMed]
Excellence in Research Award
● Epithelial and ectomesenchymal role of the type I TGF-beta receptor ALK5 during facial morphogenesis and palatal fusion. Dev Biol 2006, 296 (2): 298-314. [PubMed]
INVITED BOOK CHAPTER
● TGF-beta superfamily and mouse craniofacial development: Interplay of morphogenetic proteins and receptor signaling controls normal formation of the face. ELSEVIER Academic Press, Curr Top Dev Biol 2005, 66: 65-133. [PubMed]
MOD Best Cited Articles 2004-2005
● Craniofacial defects in mice lacking BMP type I receptor Alk2 in neural crest cells. Mech Dev. 2004, 121 (2): 173-82. [PubMed]
FIRST CP GENE THERAPY IN VITRO RCDF Award
● Tgf-beta3-induced palatal fusion is mediated by Alk-5/Smad pathway. Dev Biol. 2004, 266 (1): 96-108. [PubMed]
* * *
RESEARCH & PUBLICATION LOGISTICS REMARK
Please note that we are not a public organization, and we are not subject to state support or governmental budgets. Instead, we largely depend on self-financing and our hard work, grants, sponsorship and donations. Accordingly, we strongly prioritize purpose-driven work and scientific quality over blunt efforts and paper output quantity. We prefer confidential technology transfers and seeing practical implementation of our work in real medicine and industry, rather than engaging ourselves in self-purposed nature-measuring efforts or in various scientometry competitions. Thus, large portions of our work are protected intellectual property and often proprietary. We do not believe in "publish or perish" being the most productive research style. Our major mission is not residing in plentiful kinds of academic vanity fairs, but we focus on true helping people and other living things, on fighting diseases and eliminating various sorts of suffering and degeneration, and on wise building of profound and well-structured knowledge.
DIFFERENCES FROM CLASSIC ACADEMIA
All of the above factors significantly influence our publication policies and intellectual property protection strategies. This explains, for example: our reception of world prizes / international awards for work that was actually never published (e.g., lack of publications about our protected inventions and innovations, such as those seen on the PROJECTS subpage); or our tight and silent collaboration with business entities rather than schools and basic research institutes; our premium quality research outcomes being reserved for further proprietary development while less important results are occasionally reported on conferences or published in journals; and other differences from typical paper-oriented academic institutions. Special publishing or IP-related obligations may be implied by grant agreements or other contracts, and such cases are handled individually.
ACKNOWLEDGEMENTS
Many thanks to great thinkers and hardworking individuals that helped a lot and/or made the most significant impact on our work, staff training, ideation background, or other aspects of scientific collaboration:
Vesa Kaartinen
Want to join our team?
Interested in collaboration or joint grant development?
(e.g., NIH, NSF, ESF, Horizon 2020, etc.)
*
Contact us with enquiries or proposals:
Page updated
Google Sites
Report abuse